Orphagen Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Orphagen develops first-in-class small molecules for cancer and inflammatory disease. A clinical candidate, OR-449, for treatment of multiple cancers, is close to IND filing and could reach annual peak sales of $2B.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}